Loading...
Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients
BACKGROUND: Multitargeted tyrosine kinase inhibitors (TKIs) represent a new class of target-specific antineoplastic agents. These agents show some specific adverse events such as fatigue/asthenia, anorexia/loss of appetite, dysgeusia, diarrhea/abdominal pain, hypothyroidism, hypertension, myelosuppr...
Na minha lista:
| Udgivet i: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994328/ https://ncbi.nlm.nih.gov/pubmed/29992147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5035217 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|